The authors thank Christiane Pahrmann for technical assistance. S.S. received funding from the Deutsche Forschungsgemeinschaft (DFG) (SCHR992/3-2 and SCHR992/4-2).

All animal work should be carried out according to relevant animal care guidelines. Obtain institutional approval for animal work prior to beginning protocol.
1. Myointimal Hyperplasia Model (A)
For the intimal hyperplasia model, purchase C57BL/6J (Stock number 000664, C57BL/6J) mice at the age of 8 weeks weighing approximately 25 g. House mice for these experiments under conventional conditions; feed mice standard mouse chow and provide water ad libitum.
<ol>
	<li>Mouse preparation: Introduce the mouse to an anesthetic state with isoflurane (2%) utilizing an induction chamber.
	<ol>
		<li>Remove the abdominal hair using a hair trimmer, lay the mouse on its back and cover its nose and mouth with the facemask to assure the anesthesia.</li>
		<li>With Provo-Iodine, disinfect the abdominal area universally, followed by 80% ethanol, in two cycles.</li>
		<li>Assure the absence of reflexes by pinching the hind limb to monitor the sufficient depth of anesthesia.</li>
		<li>Separate the skin and muscle along the linea alba in two steps to expose&#160;the abdominal organs.</li>
		<li>Lay the intestines in a saline moisturized glove. Wrap the glove around the intestines to keep them moist.</li>
		<li>Attentively clear away the fatty tissue sheeting the abdominal aorta. Expose the infrarenal aorta down to its bifurcation, taking care not to injure any branch vessels.</li>
		<li>First, place a microsurgical clamp on the proximal, infrarenal aorta to shut down the blood flow. Now, apply a second distal clamp next to the aortic bifurcation.</li>
		<li>When the blood flow is interrupted, make a small incision into the aorta close to the proximal clamp.</li>
		<li>Insert the balloon-tipped catheter, which has been moisturized with 0.9% saline, and advance towards the distal clamp of the aorta.</li>
		<li>For endothelial injury, denude the aorta by inflating the balloon carefully and slowly pulling the catheter into the direction of the proximal clamp.</li>
		<li>Repeat the denudation maneuver twice.</li>
		<li>Remove the catheter and close the aortic incision using 10-0 prolene running sutures.</li>
		<li>Carefully open the distal clamp. In case of bleeding at the aortotomy site, close the clamp again, locate the bleeding and place additional interrupted stitches, as necessary.</li>
		<li>If no bleeding can be observed, slowly open the proximal clamp.</li>
		<li>An aortic pulse should be visible distally from the incision. Now the intestines can be arranged back in situ.</li>
		<li>Rinse the abdominal cavity utilizing pre-warmed sterile saline.</li>
		<li>Close the abdominal wall beginning with the muscle layer using 6-0 prolene running sutures.</li>
		<li>Next adapt the skin under the use of 5-0 prolene performing running sutures.</li>
		<li>During the time the mouse is still anesthetized, apply 4-5 mg/kg Carprofen via a subcutaneous injection.</li>
		<li>Add Metamizol to the drinking water (50 mg Metamizol per 100 ml) for pain control and continue for 3 days post surgery. Monitor animal throughout recovery. 
		Note: The observation period for this model is 28 days.</li>
	</ol>
	</li>
</ol>
2. Atherosclerosis Model (B)
For the atherosclerosis model, purchase apolipoprotein E-deficient (ApoE -/-) mice (Stock number 002052, B6.129P2-Apoetm1Unc/J) at an age of&#160;4 weeks, and then fed for 4-6 months. House mice for these experiments under conventional conditions; feed mice high lipid western diet upon arrival (Harlan Laboratories TD.88137) and provide water ad libitum for a duration of 4 to 6 months.
<ol>
	<li>Mouse preparation:
	<ol>
		<li>Feed the ApoE -/- mice with western diet beginning at 4 weeks&#160;of age. Dietary manipulation should begin directly upon arrival.</li>
		<li>Maintain western diet throughout duration of experiment.</li>
	</ol>
	</li>
</ol>
3. Analysis
<ol>
	<li>Myointimal hyperplasia model (A) 
	The region of interest in this model is the &#8220;lesion area&#8221;. Options for analysis include luminal obliteration, I/M ratio (intima/media ratio), maximal myointima thickness, myointimal area, Trichrome staining for fibrosis, and H&#38;E staining for mononuclear cells (as illustrated in Figures 1A-1C). According to the scientific question numerous other stainings like Picrosirius red for collagen, immunohistochemistry, and confocal methods can be applied.</li>
	<li>Atherosclerosis model (B) The regions of interest in this model are the aortic valve, aortic arch as well as the descending aorta. Options for analysis: Sudan red staining for lipids and trichrome staining of aortic valve, aortic arch and descending aorta (as illustrated in Figure 1D). 
	This model also yields a variety of other staining options like for example Oil Red O for neutral lipids, Picrosirius red, immunohistochemistry, and confocal methods.
	<ol>
		<li>Sudan red staining: Perform the Sudan red staining on freshly harvested aortic tissue.
		<ol>
			<li>Remove the diet 6h before harvesting.</li>
			<li>Introduce the mouse to an anesthetic state with isoflurane (2%) utilizing an induction chamber. Assure the absence of reflexes by pinching the hind limb to monitor the sufficient depth of anesthesia.</li>
			<li>Open the chest; cut off the apex of the heart and perfuse via the left ventricle, first with saline (3 ml), followed by 4% PFA (3 ml) through the aortic root to fix the aorta.</li>
			<li>Free the aorta from the root to its bifurcation. Try to remove fatty tissue as much as possible.</li>
			<li>Cut off the heart and the aortic root, and store them in 4% PFA for histology.</li>
			<li>For histology the aortic root has to carefully be placed in the paraffin block in an upright position to allow the cutting of the aortic root generating slides that display all 3 valvular leaflets.</li>
			<li>Cut one end of the aortic tree and fix it onto the silicone layer with fine pins. Open the aorta longitudinally and fix the aortic tissue.</li>
			<li>Rinse the tissue with 50% ethanol. Immerse the tissue with Sudan III staining solution for about 15 min.</li>
			<li>Rinse lightly with 50% ethanol to remove the excess Sudan III. (Note: 50% ethanol may wash the dye away.) Rinse with dH2O, and take photos for further analysis.</li>
		</ol>
		</li>
	</ol>
	</li>
</ol>

<ol>
	<li>Manuel, D. G., Leung, M., Nguyen, K., Tanuseputro, P., Johansen, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Burden+of+cardiovascular+disease+in+Canada.">Burden of cardiovascular disease in Canada.</a> Can J Cardiol. 19, 997-1004 (2003).</li><li>ER, O. B., Ma, X., Simard, T., Pourdjabbar, A., Hibbert, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pathogenesis+of+neointima+formation+following+vascular+injury.">Pathogenesis of neointima formation following vascular injury.</a> Cardiovasc Hematol Disord Drug Targets. 11, 30-39 (2011).</li><li>Ross, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+pathogenesis+of+atherosclerosis:+a+perspective+for+the+1990s.">The pathogenesis of atherosclerosis: a perspective for the 1990s.</a> Nature. 362, 801-809 (1993).</li><li>Meng, X., Zhang, F., Valji, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ultrasound+guidance+for+the+creation+of+a+small+animal+model+of+aortic+injury.">Ultrasound guidance for the creation of a small animal model of aortic injury.</a> J Vasc Interv Radiol. 22, 1193-1197 (2011).</li><li>Deuse, T., Koyanagi, T., Erben, R. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Sustained+inhibition+of+epsilon+protein+kinase+C+inhibits+vascular+restenosis+after+balloon+injury+and+stenting.">Sustained inhibition of epsilon protein kinase C inhibits vascular restenosis after balloon injury and stenting.</a> Circulation. 122, 170-178 (2010).</li><li>Schrepfer, S., Deuse, T., Sultan, K. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Inhibition+of+restenosis+development+after+mechanical+injury:+a+new+field+of+application+for+malononitrilamides.">Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides.</a> Cardiology. 108, 128-137 (2007).</li><li>Tao, M., Mauro, C. R., Yu, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+simplified+murine+intimal+hyperplasia+model+founded+on+a+focal+carotid+stenosis.">A simplified murine intimal hyperplasia model founded on a focal carotid stenosis.</a> Am J Pathol. 182, 277-287 (2013).</li><li>Kumar, A., Lindner, V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Remodeling+with+neointima+formation+in+the+mouse+carotid+artery+after+cessation+of+blood+flow.">Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow.</a> Arterioscler Thromb Vasc Biol. 17, 2238-2244 (1997).</li><li>Hua, X., Deuse, T., Michelakis, E. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Human+internal+mammary+artery+(IMA)+transplantation+and+stenting:+a+human+model+to+study+the+development+of+in-stent+restenosis.">Human internal mammary artery (IMA) transplantation and stenting: a human model to study the development of in-stent restenosis.</a> J Vis Exp. , 3663 (2012).</li><li>Daugherty, A., Whitman, S. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Quantification+of+atherosclerosis+in+mice.">Quantification of atherosclerosis in mice.</a> Methods Mol Biol. , (2003).</li><li>Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., Ross, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=ApoE-deficient+mice+develop+lesions+of+all+phases+of+atherosclerosis+throughout+the+arterial+tree.">ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.</a> Arterioscler Thromb. 14, 133-1340 (1994).</li><li>Zhang, Y., Li, L., You, J., Cao, J., Fu, X. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Effect+of+7-difluoromethyl-5,+4'-dimethoxygenistein+on+aorta+atherosclerosis+in+hyperlipidemia+ApoE(-/-)+mice+induced+by+a+cholesterol-rich+diet.">Effect of 7-difluoromethyl-5, 4'-dimethoxygenistein on aorta atherosclerosis in hyperlipidemia ApoE(-/-) mice induced by a cholesterol-rich diet.</a> Drug Des Devel Ther. 7, 233-242 (2013).</li><li>Rudolph, T. K., Rudolph, V., Edreira, M. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Nitro-fatty+acids+reduce+atherosclerosis+in+apolipoprotein+E-deficient+mice.">Nitro-fatty acids reduce atherosclerosis in apolipoprotein E-deficient mice.</a> Arterioscler Thromb Vasc Biol. 30, 938-9345 (2010).</li><li>Rondelet, B., Kerbaul, F., Motte, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Bosentan+for+the+prevention+of+overcirculation-induced+experimental+pulmonary+arterial+hypertension.">Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension.</a> Circulation. 107, 1329-1335 (2003).</li><li>Zeibig, S., Li, Z., Wagner, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Effect+of+the+oxLDL+binding+protein+Fc-CD68+on+plaque+extension+and+vulnerability+in+atherosclerosis.">Effect of the oxLDL binding protein Fc-CD68 on plaque extension and vulnerability in atherosclerosis.</a> Circ Res. 108, 695-703 (2011).</li><li>Painter, T. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Myointimal+hyperplasia:+pathogenesis+and+implications.+2.+Animal+injury+models+and+mechanical+factors.">Myointimal hyperplasia: pathogenesis and implications. 2. Animal injury models and mechanical factors.</a> Artificial organs. 15, 103-118 (1991).</li><li>Nitschke, Y., Weissen-Plenz, G., Terkeltaub, R., Rutsch, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Npp1+promotes+atherosclerosis+in+ApoE+knockout+mice.">Npp1 promotes atherosclerosis in ApoE knockout mice.</a> Journal of cellular and molecular. 15, 2273-2283 (2011).</li></ol>

The authors have nothing to disclose.

Although both diseases result in similar symptoms in the patient, the underlying mechanisms of plaque development and therefore the treatment approaches are very different2. In different forms of arterial stenosis the clinical findings in the patients as well as the timeframe of plaque development depend on the underlying mechanism.
Depending on the clinical findings in the patient, different methods of sample analysis must be performed5,15. It is necessary to adapt the a...

In industrialized nations ischemic heart disease remains a leading cause of mortality1. The causes for coronary artery stenosis are manifold and include myointimal hyperplasia as well as atherosclerosis, with revascularization remaining the most common treatment strategy2. Research models that clearly distinguish between the mechanistic pathways of intimal hyperplasia and atherosclerosis are essential to investigate the pathobiological and pathophysiological processes in arterial plaque development. In this video two different mouse models used to study either the development of myointimal hyperplasia or atherosclerosis are introduced.
Myointimal hyperplasia is postulated to form via the &#8220;response-to-injury&#8221; paradigm originally described for atherosclerosis3. The mechanical disruption of the endothelial layer leads to an intense remodeling enhanced by paracrine effects. There are several different animal models commonly used to study myointimal hyperplasia. Some groups use metal devices in the ascending aorta of rats4. The aortic denudation model performed with a balloon catheter is also commonly used in laboratory rats5,6. The intimal hyperplasia model performed in laboratory mice7 implements ligation of the carotid artery and induces myointimal lesions8. In our lab, the abdominal aortic denudation model &#8211; to study the development of myointimal hyperplasia &#8211; as well as a humanized stent restenosis model9 are commonly used. This video emphasizes that choosing the proper experimental animal model is crucial for mechanistic or pathophysiologic studies of arterial stenosis.
Myointimal hyperplasia models must be distinguished from atherosclerosis models. For the latter, apolipoprotein E-deficient (ApoE -/-) mice in combination with western diet are commonly used to induce atherosclerotic lesions10,11,12,13. Examples for the induction of both of these types of myointimal disease in mice are shown here, along with different model-adapted options to analyze vessel stenosis14.

<table border="0" cellpadding="0" cellspacing="0" style="width:617px;" width="618">
	<colgroup>
		<col />
		<col />
		<col />
		<col />
	</colgroup>
	<tbody>
		<tr height="17">
			<td height="17" style="height:17px;width:156px;">Name</td>
			<td style="width:183px;">Company</td>
			<td style="width:139px;">Catalog number</td>
			<td style="width:140px;">Comments</td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">Thyoglycollate Broth 3%</td>
			<td>Fluka</td>
			<td align="right">70157</td>
			<td>powder</td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">PFA 4%</td>
			<td>Electron Microscopy Sciences</td>
			<td>#157135S</td>
			<td align="right">20%</td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">Sudan III staining solution</td>
			<td>Sigma Aldrich</td>
			<td>S4131</td>
			<td>powder</td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">mouse C57BL/6J</td>
			<td>Jackson Laboratories</td>
			<td>&#160;Stock # 0006664</td>
			<td></td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">mouse ApoE-/-</td>
			<td>Jackson Laboratories</td>
			<td>&#160;Stock #002052</td>
			<td></td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">Western Diet</td>
			<td>Harlan Laboratories</td>
			<td>TD.88137</td>
			<td></td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">hair clipper</td>
			<td>WAHL</td>
			<td>8786-451A ARCO SE</td>
			<td></td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">Forene</td>
			<td>Abbott</td>
			<td></td>
			<td>Isoflurane</td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">microsurgical clamp</td>
			<td>Fine Science Tools</td>
			<td>18055-04</td>
			<td>Micro-Serrefine - 4mm</td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">clamp applicator</td>
			<td>Fine Science Tools</td>
			<td>18056-14</td>
			<td></td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">catheter</td>
			<td></td>
			<td></td>
			<td></td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">10-0 prolene suture</td>
			<td>Ethicon</td>
			<td>788G</td>
			<td></td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">6-0 prolene suture</td>
			<td>Ethicon</td>
			<td>8709H</td>
			<td></td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">5-0 prolene suture</td>
			<td>Ethicon</td>
			<td>EH7229H</td>
			<td></td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">Rimadyl</td>
			<td>Pfizer&#160;</td>
			<td></td>
			<td>Carprofen</td>
		</tr>
		<tr height="17">
			<td height="17" style="height:17px;">Metacam 1.5mg/ml</td>
			<td>Boehringer Ingelheim</td>
			<td></td>
			<td>Metamizol</td>
		</tr>
	</tbody>
</table>

inducing myointimal hyperplasia versus atherosclerosis in mice: an introduction of two valid models

Various in vivo laboratory rodent models for the induction of artery stenosis have been established to mimic diseases that include arterial plaque formation and stenosis, as observed for example in ischemic heart disease. Two highly reproducible mouse models&#160;&#8211;&#160;both resulting in artery stenosis but each underlying a different pathway of development&#160;&#8211; are introduced here. The models represent the two most common causes of artery stenosis; namely one mouse model for each myointimal hyperplasia, and atherosclerosis are shown. To induce myointimal hyperplasia, a balloon catheter injury of the abdominal aorta is performed. For the development of atherosclerotic plaque, the ApoE -/- mouse model in combination with western fatty diet is used. Different model-adapted options for the measurement and evaluation of the results are named and described in this manuscript. The introduction and comparison of these two models provides information for scientists to choose the appropriate artery stenosis model in accordance to the scientific question asked.

Figure 1 shows different analysis options and the induced disease state for both models. For the intimal hyperplasia model, the analysis of representative cross sections in trichrome staining is shown. From these cross sections, results like I/M ratios, maximum plaque thickness, maximum intimal thickness in the lumen, luminal obliteration in percent, as well as plaque area can be measured and calculated.
To evaluate the outcome of the atherosclerosis model, all methods named a...

Watch this Scientific Journal Video about Inducing Myointimal Hyperplasia Versus Atherosclerosis in Mice: An Introduction of Two Valid Models at JoVE.com

Inducing Myointimal Hyperplasia Versus Atherosclerosis in Mice: An Introduction of Two Valid Models

This video shows two models of intimal plaque development in murine arteries and emphasizes the differences in myointimal hyperplasia and atherosclerosis.

Various in vivo laboratory rodent models for the induction of artery stenosis have been established to mimic diseases that include arterial plaque ...

inducing-myointimal-hyperplasia-versus-atherosclerosis-mice-an

Research

JoVE Journal

Medicine

12.0K Views.  University Hospital Hamburg. This video shows two models of intimal plaque development in murine arteries and emphasizes the differences in myointimal hyperplasia and atherosclerosis.